ReAx Biotechnologies的封面图片
ReAx Biotechnologies

ReAx Biotechnologies

生物技术研究

Chicago，IL 749 位关注者

Leveraging next-generation chemical proteomic platforms to discover small molecule therapeutics for high-value targets.

关注

关于我们

ReAx is a Chicago-based, pre-clinical company that is applying next generation chemical proteomic platforms to discover, optimize and validate small molecules directly in cells. The ReAx pipeline enables interrogation of proteomic ‘dark matter’ – a landscape that is rarely studied, much less exploited for ligand discovery against high-value protein targets. By integrating our platforms with innovative chemistry, disease biology, and computational methods, we hope to deliver first-in-class therapeutics in oncology and immunological disease indications.

网站
https://www.reaxbio.com
所属行业
生物技术研究
规模
2-10 人
总部
Chicago，IL
类型
私人持股

地点

ReAx Biotechnologies员工

查看全部员工

相似主页

查看职位